Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles

doi:10.4239/wjd.118650

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

(0)

(1)

(0)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Jun 15, 2026; 17(6): 118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650

Table 1 The content of 8 ingredients of Tangwang formula were detected by high-performance liquid chromatography (mean ± SD, n = 3)

Number	Compound name	Standard curve	Content (μg/100 mg)	Source
1	P-Coumaric acid (CAS No. 501-98-4)	y = 21.85x - 5.99, r = 0.99947	17.03 ± 1.34	Lycium barbarum L. (Lycii Fructus), TAL
2	Calycosin-7-O-β-D-glucoside (CAS No. 20633-67-4)	y = 18.38x - 16.94, r = 0.9991	48.10 ± 3.28	AMB
3	Isorhamnetin-3-O-neohespeidoside (CAS No. 55033-90-4)	y = 12.71x + 6.18, r = 0.99983	19.96 ± 0.97	EBK, TAL
4	Ononin (CAS No. 486-62-4)	y = 22.37x - 14.94, r = 0.99987	20.84 ± 1.29	AMB, CCP
5	Calycosin (CAS No. 20575-57-9)	y = 25.05x + 31.40, r = 0.9999	11.71 ± 0.64	AMB
6	Cinnamic acid (CAS No. 140-10-3)	y = 71.62x - 19.12, r = 0.99988	20.92 ± 1.41	CCP
7	Naringenin (CAS No. 480-41-1)	y = 14.49x + 15.74, r = 0.99963	6.48 ± 0.33	EBK, TAL, CCP
8	Formononetin (CAS No. 485-72-3)	y = 32.87x - 37.86, r = 0.99992	4.81 ± 0.42	AMB, CCP

AMB: Bunge (Astragali Radix); CCP: Cinnamomum cassia Presl (Cinnamomi Ramulus); EBK: Eriocaulon buergerianum Koern. (Eriocauli Flos); TAL: Typha angustifolia L. (Typhae Pollen).

Full Size Table

Citation: Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; 17(6): 118650
URL: https://www.wjgnet.com/1948-9358/full/v17/i6/118650.htm
DOI: https://dx.doi.org/10.4239/wjd.118650

Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; 17(6): 118650 [DOI: 10.4239/wjd.118650]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.